Investor Growth Equity Opportunities 18 VGE, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Growth Equity Opportunities 18 VGE, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-18 13D/A CELC / Celcuity Inc. 1,520,001 3,535,561
2025-08-15 13D/A XFOR / X4 Pharmaceuticals, Inc. 15,742,792 2,243,658
2023-07-28 13D GOSS / Gossamer Bio, Inc. 18,793,076
2023-05-26 13D/A XFOR / X4 Pharmaceuticals, Inc. 12,136,793 15,742,792
2022-12-20 13D/A XFOR / X4 Pharmaceuticals, Inc. 6,878,157 12,136,793
2022-09-12 13D/A CELC / Celcuity Inc. 1,250,001 1,520,001
2022-07-19 13D XFOR / X4 Pharmaceuticals, Inc. 6,878,157
2022-05-24 13D CELC / Celcuity Inc. 1,250,001